B
IDXX icon

Bailard’s Idexx Laboratories IDXX Stock Holding History

Bailard’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
3,995
+1,842
+86% +$1.03M 0.04% 257
2026
Q1 		$1.21M Sell
2,153
-889
-29% -$570K 0.03% 296
2025
Q4 		$2.06M Buy
3,042
+479
+19% +$326K 0.05% 226
2025
Q3 		$1.64M Buy
2,563
+615
+32% +$373K 0.04% 266
2025
Q2 		$1.04M Buy
+1,948
New +$932K 0.02% 318
2022
Q2 		– Sell
-502
Closed -$275K – 736
2022
Q1 		$275K Buy
502
+159
+46% +$83.6K 0.01% 561
2021
Q4 		$226K Buy
+343
New +$215K 0.01% 647
2021
Q2 		– Sell
-729
Closed -$357K – 726
2021
Q1 		$357K Buy
729
+140
+24% +$70.1K 0.01% 462
2020
Q4 		$294K Buy
+589
New +$264K 0.01% 446

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bailard's IDXX Position: Q2 2026 in Review

Bailard increased its Idexx Laboratories (IDXX) stake by 86% in Q2 2026, buying an estimated $1.03M and bringing the position to 3,995 shares worth $2.1M. The position accounts for 0.04% of the portfolio, ranked #257.

Bailard first reported a position in IDXX in Q4 2020 and has held it in 9 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bailard held 3,995 shares of Idexx Laboratories worth $2.1M as of Q2 2026.
  • Bailard bought 1,842 Idexx Laboratories shares in Q2 2026, an estimated $1.03M.
  • Idexx Laboratories made up 0.04% of Bailard's portfolio in Q2 2026, its #257 holding.
  • Bailard first reported a position in Idexx Laboratories in Q4 2020 and has held it in 9 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.